摘要:
目的:评价南京地区医院喹诺酮类药的应用情况.方法:对南京地区35家医院2009-2011年常用喹诺酮类药的销售金额、用药频度(DDDs)和日均费用(DDC)等进行回顾性统计、分析.结果:该地区医院喹诺酮类药的销售金额和DDDs整体呈逐年下降趋势,各年度的销售金额分别为83 172 965.10、76 225 513.46、62 876 382.09元,年均增长率为-13.05%;各年度的DDDs分别为2 910 542.73、2 478 391.70、2 512 051.15,年均增长率为-7.10%.左氧氟沙星的DDDs一直排在第1住,其DDDs分别为1 102 525.40、992 019.80、1 290 872.60,占喹诺酮类药总DDDs的42.85%;莫西沙星注射剂的销售金额和DDDs逐年上升,各年度的销售金额分别为11 781 874.56、13 120 229.39、15 527 001.24元,各年度的DDDs分别为41 092.00、45 903.00、56 016.00,各年度DDC分别为286.72、285.83、277.19元.除帕珠沙星注射剂外,其他品种的销售金额和DDDs皆呈下降趋势.2010年淘汰了3种药(吡哌酸、培氟沙星、妥舒沙星)并引进了1种新药(安妥沙星).结论:该地区医院喹诺酮类药的应用逐年减少,但为延缓细菌耐药性的产生,仍应继续严格控制喹诺酮类药的应用,以确保临床用药安全、有效和经济.%OBJECTIVE: To evaluate the utilization of quinolones in the hospitals from Nanjing areas. METHEDS: By a retrospective study, the consumption sum, DDDs and DDC of quinolones in 35 hospitals from Nanjing area during 2009 - 2011 were analyzed statistically in respect of consumption sum, DDDs and DDC, etc. RESULTS: During 3-year period, the consumption sum and DDDs of quinolones in 35 hospitals reduced year by year. The consumption sum were 83 172 965.10 yuan, 76 225 513.46 yuan,62 876 382.09 yuan, respectively, with annual growth rate of -13.05%. DDDs were 2 910 542.73,2 478 391.70 and 2 512 051.15, respectively, with annual growth rate of -7.10%. DDDs of levofloxacin had ranked first during 3-year period. The DDDs were 1 102 525.40, 992 019.80 and 1 290 872.60 respectively, accounting for 42.85% of the total DDDs of quinolones. The consumption sum and DDDs of Moxifloxacin injection increased year by year; the consumption sum were 11 781 874.56 yuan, 13 120 229.39 yuan and 15 527 001.24 yuan respectively; DDDs were 41 092.00, 45 903.00 and 56 016.00, respectively; DDC were 286.72 yuan, 285.83 yuan and 277.19 yuan, respectively. Except for Pazufloxacin injection, the consumption sum and DDDs of other varieties exhibited a downward trend. In 2010, 3 kinds of quinolones(pipemidic acid, pefloxacin, tosuflox-acin)were eliminated and a new variety of quinolones(antofloxacin) was introduced. CONCLUSIONS: The application of quinolones in 35 hospitals from Nanjing area is decreasing year by year. To delay the generation of bacterial resistance, the strict control of the application of quinolones is recommended to ensure safe, effective and economical use of drugs in the clinic.